Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesalazine and/or Lactobacillus Casei in Maintaining Remission of Symptomatic Uncomplicated Diverticular Disease of the Colon: a Double-blind, Double-dummy, Placebo-controlled Study

NCT01534754 is registered in ClinicalTrials.gov with Hospital Cristo Re as lead sponsor.

NCT NCT01534754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01534754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesalazine and/or Lactobacillus Casei in Maintaining Remission of Symptomatic Uncomplicated Diverticular Disease of the Colon: a Double-blind, Double-dummy, Placebo-controlled Study
Lead sponsor
Hospital Cristo Re
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2011
Enrollment
250 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

diverticular disease of the colon